NCT05514171View on ClinicalTrials.gov

Prospective Registry of Patients With Pancreas Adenocarcinoma Resectable and Borderline

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

June 30, 2023

Study Completion Date

December 31, 2023

Conditions
Chemotherapy EffectPancreas Cancer
Interventions
PROCEDURE

Neoadyuvant therapy

Patients of group neoadyuvant therapy will receive any chemotherapy treatment before surgery

Trial Locations (1)

Unknown

Hospital del Mar, Barcelona

All Listed Sponsors
lead

Hospital del Mar

OTHER